SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007172
Filing Date
2023-03-10
Accepted
2023-03-10 08:00:38
Documents
35
Period of Report
2023-03-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55709
2 ex99-1.htm EX-99.1 18131
3 ex99-1_001.jpg GRAPHIC 225755
4 ex99-1_002.jpg GRAPHIC 312027
5 ex99-1_003.jpg GRAPHIC 288988
6 ex99-1_004.jpg GRAPHIC 259046
7 ex99-1_005.jpg GRAPHIC 214082
8 ex99-1_006.jpg GRAPHIC 199792
9 ex99-1_007.jpg GRAPHIC 257062
10 ex99-1_008.jpg GRAPHIC 341974
11 ex99-1_009.jpg GRAPHIC 324577
12 ex99-1_010.jpg GRAPHIC 226333
13 ex99-1_011.jpg GRAPHIC 262357
14 ex99-1_012.jpg GRAPHIC 199352
15 ex99-1_013.jpg GRAPHIC 239585
16 ex99-1_014.jpg GRAPHIC 262784
17 ex99-1_015.jpg GRAPHIC 203185
18 ex99-1_016.jpg GRAPHIC 358033
19 ex99-1_017.jpg GRAPHIC 312580
20 ex99-1_018.jpg GRAPHIC 196644
21 ex99-1_019.jpg GRAPHIC 306050
22 ex99-1_020.jpg GRAPHIC 147072
23 ex99-1_021.jpg GRAPHIC 161646
24 ex99-1_022.jpg GRAPHIC 289979
  Complete submission text file 0001493152-23-007172.txt   7948386

Data Files

Seq Description Document Type Size
25 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20230309.xsd EX-101.SCH 3218
26 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anix-20230309_lab.xml EX-101.LAB 34240
27 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20230309_pre.xml EX-101.PRE 22353
29 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3621
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 23721666
SIC: 2834 Pharmaceutical Preparations